Echocardiography in the diagnostic evaluation and phenotyping of heart failure with preserved ejection fraction.

[1]  G. Sinagra,et al.  [ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: what's new?] , 2022, Giornale italiano di cardiologia.

[2]  M. Obokata,et al.  Functional Tricuspid Regurgitation and Right Atrial Remodeling in Heart Failure With Preserved Ejection Fraction. , 2021, The American journal of cardiology.

[3]  P. Noseworthy,et al.  Prevalence of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction. , 2021, JAMA cardiology.

[4]  A. Fraser,et al.  Left atrial conduit flow rate at baseline and during exercise: an index of impaired relaxation in HFpEF patients , 2021, ESC heart failure.

[5]  B. Borlaug,et al.  Clinical Phenogroups in Heart Failure with Preserved Ejection Fraction. , 2021, Heart failure clinics.

[6]  Christopher J. Rush,et al.  Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction. , 2021, JAMA cardiology.

[7]  D. Burkhoff,et al.  Obesity, venous capacitance, and venous compliance in heart failure with preserved ejection fraction , 2021, European journal of heart failure.

[8]  M. Takemura,et al.  Pulmonary Vascular Alterations on CT Imaging and Outcomes in Heart Failure with Preserved Ejection Fraction: a Preliminary Data. , 2021, Journal of cardiac failure.

[9]  M. Obokata,et al.  Association between lung ultrasound B‐lines and exercise‐induced pulmonary hypertension in patients with connective tissue disease , 2021, Echocardiography.

[10]  D. J. Veldhuisen,et al.  Epicardial fat in heart failure with reduced versus preserved ejection fraction , 2021, European journal of heart failure.

[11]  Sanjiv J. Shah,et al.  Disproportionate left atrial myopathy in heart failure with preserved ejection fraction among participants of the PROMIS-HFpEF study , 2021, Scientific Reports.

[12]  R. Wachter,et al.  Exercise-Stress Real-time Cardiac Magnetic Resonance Imaging for Non-Invasive Characterisation of Heart Failure with Preserved Ejection Fraction: The HFpEF Stress Trial. , 2021, Circulation.

[13]  P. Ponikowski,et al.  Prediction of AF in Heart Failure With Preserved Ejection Fraction: Incremental Value of Left Atrial Strain. , 2021, JACC. Cardiovascular imaging.

[14]  M. Obokata,et al.  Impact of Right Atrial Remodeling in Heart Failure with Preserved Ejection Fraction. , 2020, Journal of cardiac failure.

[15]  M. Jensen,et al.  Pathophysiologic importance of visceral adipose tissue in women with heart failure and preserved ejection fraction. , 2020, European heart journal.

[16]  M. Obokata,et al.  Independent and incremental prognostic value of semiquantitative measures of tricuspid regurgitation severity in heart failure with preserved ejection fraction. , 2020, European heart journal cardiovascular Imaging.

[17]  N. Koitabashi,et al.  Pathophysiological role of fatty acid‐binding protein 4 in Asian patients with heart failure and preserved ejection fraction , 2020, ESC heart failure.

[18]  L. Lerman,et al.  Coronary microvascular dysfunction is associated with exertional haemodynamic abnormalities in patients with heart failure with preserved ejection fraction , 2020, European journal of heart failure.

[19]  M. Obokata,et al.  Atrial Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation. , 2020, Journal of the American College of Cardiology.

[20]  M. LeWinter,et al.  Heart Rate–Induced Myocardial Ca2+ Retention and Left Ventricular Volume Loss in Patients With Heart Failure With Preserved Ejection Fraction , 2020, Journal of the American Heart Association.

[21]  Sanjiv J. Shah,et al.  Association of Coronary Microvascular Dysfunction with Heart Failure Hospitalizations and Mortality in Heart Failure with Preserved Ejection Fraction - a follow-up in the PROMIS-HFpEF study. , 2020, Journal of cardiac failure.

[22]  H. Thiele,et al.  Transcatheter tricuspid valve repair in the setting of heart failure with preserved or reduced left ventricular ejection fraction , 2020, European journal of heart failure.

[23]  Sanjiv J. Shah,et al.  Endomyocardial Biopsy Characterization of Heart Failure With Preserved Ejection Fraction and Prevalence of Cardiac Amyloidosis. , 2020, JACC. Heart failure.

[24]  M. Obokata,et al.  Hemodynamic and Functional Impact of Epicardial Adipose Tissue in Heart Failure With Preserved Ejection Fraction. , 2020, JACC. Heart failure.

[25]  M. Rienstra,et al.  Epicardial Adipose Tissue and Invasive Hemodynamics in Heart Failure With Preserved Ejection Fraction. , 2020, JACC. Heart failure.

[26]  M. Obokata,et al.  Obesity-Related Heart Failure with Preserved Ejection Fraction: Pathophysiology, Diagnosis, and Potential Therapies. , 2020, Heart failure clinics.

[27]  N. Houstis,et al.  Impaired Exercise Tolerance in Heart Failure With Preserved Ejection Fraction: Quantification of Multiorgan System Reserve Capacity. , 2020, JACC. Heart failure.

[28]  B. Borlaug,et al.  Performance and Interpretation of Invasive Hemodynamic Exercise Testing. , 2020, Chest.

[29]  B. Gerber,et al.  Right Ventricular Global Longitudinal Strain and Outcomes in Heart Failure with Preserved Ejection Fraction. , 2020, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[30]  M. Volpe,et al.  The neglected issue of cardiac amyloidosis in trials on heart failure with preserved ejection fraction in the elderly , 2020, European journal of heart failure.

[31]  B. Borlaug.  Evaluation and management of heart failure with preserved ejection fraction , 2020, Nature Reviews Cardiology.

[32]  Rahul C. Deo,et al.  Research Priorities for Heart Failure With Preserved Ejection Fraction , 2020, Circulation.

[33]  Sanjiv J. Shah,et al.  Quality of life in heart failure with preserved ejection fraction: importance of obesity, functional capacity, and physical inactivity , 2020, European journal of heart failure.

[34]  W. Tang,et al.  Comprehensive Diagnostic Evaluation of Cardiovascular Physiology in Patients With Pulmonary Vascular Disease , 2020, Circulation. Heart failure.

[35]  J. Núñez,et al.  Beta‐blockers withdrawal in patients with heart failure with preserved ejection fraction and chronotropic incompetence: Effect on functional capacity rationale and study design of a prospective, randomized, controlled trial (The Preserve‐HR trial) , 2020, Clinical cardiology.

[36]  Francesca N. Delling,et al.  Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association , 2020, Circulation.

[37]  A. Natali,et al.  Haemodynamic and metabolic phenotyping of hypertensive patients with and without heart failure by combining cardiopulmonary and echocardiographic stress test , 2020, European journal of heart failure.

[38]  R. Nishimura,et al.  Functional mitral regurgitation and left atrial myopathy in heart failure with preserved ejection fraction , 2020, European journal of heart failure.

[39]  N. Houstis,et al.  Exercise Pulmonary Hypertension Predicts Clinical Outcomes in Patients With Dyspnea on Effort. , 2020, Journal of the American College of Cardiology.

[40]  M. Obokata,et al.  Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction: Understanding Mechanisms by Using Noninvasive Methods. , 2020, JACC. Cardiovascular imaging.

[41]  A. Lerman,et al.  Endothelium‐dependent and independent coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction , 2019, European journal of heart failure.

[42]  M. Galderisi,et al.  Cardiopulmonary exercise testing and echocardiographic exam: an useful interaction , 2019, Cardiovascular ultrasound.

[43]  Sanjiv J. Shah,et al.  Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction. , 2019, Journal of the American College of Cardiology.

[44]  S. Juraschek,et al.  Association of β-Blocker Use With Heart Failure Hospitalizations and Cardiovascular Disease Mortality Among Patients With Heart Failure With a Preserved Ejection Fraction , 2019, JAMA network open.

[45]  V. Melenovský,et al.  Noninvasive evaluation of pulmonary artery pressure during exercise: the importance of right atrial hypertension , 2019, European Respiratory Journal.

[46]  Akshay S. Desai,et al.  Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure , 2019, Circulation.

[47]  R. Naeije,et al.  Right Ventricular-Arterial Uncoupling During Exercise in Heart Failure With Preserved Ejection Fraction: Role of Pulmonary Vascular Dysfunction. , 2019, Chest.

[48]  C. Ayers,et al.  Phenomapping of patients with heart failure with preserved ejection fraction using machine learning‐based unsupervised cluster analysis , 2019, European journal of heart failure.

[49]  G. Cho,et al.  Myocardial Strain for Identification of β-Blocker Responders in Heart Failure with Preserved Ejection Fraction. , 2019, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[50]  W. Tay,et al.  Association of obesity with heart failure outcomes in 11 Asian regions: A cohort study , 2019, PLoS medicine.

[51]  Akshay S. Desai,et al.  Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. , 2019, The New England journal of medicine.

[52]  Erwan Donal,et al.  How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). , 2019, European heart journal.

[53]  Sanjiv J. Shah,et al.  ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI EXPERT CONSENSUS RECOMMENDATIONS FOR MULTIMODALITY IMAGING IN CARDIAC AMYLOIDOSIS: PART 1 OF 2-EVIDENCE BASE AND STANDARDIZED METHODS OF IMAGING. , 2019, Journal of cardiac failure.

[54]  M. LeWinter,et al.  Beta-Blocker Cessation in Stable Outpatients with Heart Failure with a Preserved Ejection Fraction. , 2019, Journal of cardiac failure.

[55]  S. Akers,et al.  Right Atrial Phasic Function in Heart Failure With Preserved and Reduced Ejection Fraction. , 2019, JACC. Cardiovascular imaging.

[56]  G. Lewis,et al.  Differential Clinical Profiles, Exercise Responses and Outcomes Associated with Existing HFpEF Definitions. , 2019, Circulation.

[57]  R. Carter,et al.  Left atrial strain and compliance in the diagnostic evaluation of heart failure with preserved ejection fraction , 2019, European journal of heart failure.

[58]  N. Ohte,et al.  Effects of exercise training on cardiac function, exercise capacity, and quality of life in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials , 2019, Heart Failure Reviews.

[59]  M. Obokata,et al.  Left atrial dysfunction: the next key target in heart failure with preserved ejection fraction , 2019, European journal of heart failure.

[60]  Jeroen J. Bax,et al.  Morphologic Types of Tricuspid Regurgitation: Characteristics and Prognostic Implications. , 2019, JACC. Cardiovascular imaging.

[61]  V. Melenovský,et al.  The neurohormonal basis of pulmonary hypertension in heart failure with preserved ejection fraction. , 2019, European heart journal.

[62]  B. Gerber,et al.  Additional Prognostic Value of 2D Right Ventricular Speckle-Tracking Strain for Prediction of Survival in Heart Failure and Reduced Ejection Fraction: A Comparative Study With Cardiac Magnetic Resonance. , 2019, JACC. Cardiovascular imaging.

[63]  M. Obokata,et al.  The Role of Echocardiography in Heart Failure with Preserved Ejection Fraction: What Do We Want from Imaging? , 2019, Heart failure clinics.

[64]  T. Marwick,et al.  Impaired left atrial strain predicts abnormal exercise haemodynamics in heart failure with preserved ejection fraction , 2019, European journal of heart failure.

[65]  G. Simonneau,et al.  An overview of the 6th World Symposium on Pulmonary Hypertension , 2019, European Respiratory Journal.

[66]  V. Melenovský,et al.  Deterioration in right ventricular structure and function over time in patients with heart failure and preserved ejection fraction , 2018, European heart journal.

[67]  A. Shah,et al.  Resting Heart Rate and Chronotropic Response to Exercise: Prognostic Implications in Heart Failure Across the Left Ventricular Ejection Fraction Spectrum. , 2018, Journal of cardiac failure.

[68]  D. Celermajer,et al.  Tricuspid regurgitation is associated with increased mortality independent of pulmonary pressures and right heart failure: a systematic review and meta-analysis , 2018, European heart journal.

[69]  M. Obokata,et al.  Left Atrial Contracture or Failure to Dilate. , 2018, Circulation. Heart failure.

[70]  R. Carter,et al.  A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction , 2018, Circulation.

[71]  Sanjiv J. Shah,et al.  Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF , 2018, European heart journal.

[72]  W. Shimizu,et al.  Heart failure with preserved ejection fraction in Asia , 2018, European journal of heart failure.

[73]  V. Melenovský,et al.  Haemodynamics, dyspnoea, and pulmonary reserve in heart failure with preserved ejection fraction , 2018, European heart journal.

[74]  M. Obokata,et al.  The β-Adrenergic Agonist Albuterol Improves Pulmonary Vascular Reserve in Heart Failure with Preserved Ejection Fraction: A Randomized Controlled Trial , 2018, Journal of Cardiac Failure.

[75]  V. Melenovský,et al.  Myocardial Injury and Cardiac Reserve in Patients With Heart Failure and Preserved Ejection Fraction. , 2018, Journal of the American College of Cardiology.

[76]  D. Atar,et al.  Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial , 2018, Circulation. Heart failure.

[77]  V. Melenovský,et al.  Exercise unmasks distinct pathophysiologic features in heart failure with preserved ejection fraction and pulmonary vascular disease , 2018, European heart journal.

[78]  M. Obokata,et al.  The strengths and limitations of E/e' in heart failure with preserved ejection fraction , 2018, European journal of heart failure.

[79]  A. Voors,et al.  Right ventricular-vascular coupling in heart failure with preserved ejection fraction and pre- vs. post-capillary pulmonary hypertension , 2018, European heart journal cardiovascular Imaging.

[80]  M. Gladwin,et al.  Association Between Hemodynamic Markers of Pulmonary Hypertension and Outcomes in Heart Failure With Preserved Ejection Fraction , 2018, JAMA cardiology.

[81]  Akshay S. Desai,et al.  Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction , 2018, European heart journal.

[82]  A. Pandey,et al.  Relative Impairments in Hemodynamic Exercise Reserve Parameters in Heart Failure With Preserved Ejection Fraction: A Study-Level Pooled Analysis. , 2018, JACC. Heart failure.

[83]  B. Gersh,et al.  High Prevalence of Occult Heart Failure With Preserved Ejection Fraction Among Patients With Atrial Fibrillation and Dyspnea. , 2018, Circulation.

[84]  Sanjiv J. Shah,et al.  Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology , 2018, European journal of heart failure.

[85]  W. Edwards,et al.  Global Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated With Heart Failure and Preserved or Reduced Ejection Fraction , 2017, Circulation.

[86]  L. Ling,et al.  Right ventricular dysfunction in left‐sided heart failure with preserved versus reduced ejection fraction , 2017, European journal of heart failure.

[87]  I. V. Van Gelder,et al.  Right Heart Dysfunction in Heart Failure With Preserved Ejection Fraction: The Impact of Atrial Fibrillation. , 2017, Journal of cardiac failure.

[88]  H. Lei,et al.  Pulmonary Vascular Resistance During Exercise Predicts Long-Term Outcomes in Heart Failure With Preserved Ejection Fraction. , 2017, Journal of cardiac failure.

[89]  J. Mascherbauer,et al.  Wedge Pressure Rather Than Left Ventricular End-Diastolic Pressure Predicts Outcome in Heart Failure With Preserved Ejection Fraction. , 2017, JACC. Heart failure.

[90]  M. Obokata,et al.  Left Ventricular Filling Pressures in Heart Failure With Preserved Ejection Fraction: Is the Tail Now Wagging the Dog? , 2017, JACC. Heart failure.

[91]  M. Obokata,et al.  Is it time to recognize a new phenotype? Heart failure with preserved ejection fraction with pulmonary vascular disease , 2017, European heart journal.

[92]  M. Guazzi,et al.  Left Atrial Function Dynamics During Exercise in Heart Failure: Pathophysiological Implications on the Right Heart and Exercise Ventilation Inefficiency. , 2017, JACC. Cardiovascular imaging.

[93]  M. Guazzi,et al.  RV Contractile Function and its Coupling to Pulmonary Circulation in Heart Failure With Preserved Ejection Fraction: Stratification of Clinical Phenotypes and Outcomes. , 2017, JACC. Cardiovascular imaging.

[94]  R. Frantz,et al.  Unraveling the RV Ejection Doppler Envelope: Insight Into Pulmonary Artery Hemodynamics and Disease Severity. , 2017, JACC. Cardiovascular imaging.

[95]  R. Arena,et al.  Cardiopulmonary Exercise Testing: What Is its Value? , 2017, Journal of the American College of Cardiology.

[96]  E. Schwammenthal,et al.  Echo-Doppler estimation of left ventricular filling pressure: results of the multicentre EACVI Euro-Filling study , 2017, European heart journal cardiovascular Imaging.

[97]  B. Pieske,et al.  Left ventricular longitudinal systolic function analysed by 2D speckle-tracking echocardiography in heart failure with preserved ejection fraction: a meta-analysis , 2017, Open Heart.

[98]  G. Felker,et al.  Role of Volume Redistribution in the Congestion of Heart Failure , 2017, Journal of the American Heart Association.

[99]  V. Melenovský,et al.  Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction , 2017, Circulation.

[100]  M. Desai,et al.  Reliability of updated left ventricular diastolic function recommendations in predicting elevated left ventricular filling pressure and prognosis , 2017, American heart journal.

[101]  Joshua A. Salomon,et al.  Health Effects of Overweight and Obesity in 195 Countries over 25 Years. , 2017, The New England journal of medicine.

[102]  Shannon M. Dunlay,et al.  Epidemiology of heart failure with preserved ejection fraction , 2017, Nature Reviews Cardiology.

[103]  C. Lücke,et al.  Influence of Left Atrial Function on Exercise Capacity and Left Ventricular Function in Patients With Heart Failure and Preserved Ejection Fraction , 2017, Circulation. Cardiovascular imaging.

[104]  M. Takeuchi,et al.  Ventricular-Arterial Coupling and Exercise-Induced Pulmonary Hypertension During Low-Level Exercise in Heart Failure With Preserved or Reduced Ejection Fraction. , 2017, Journal of cardiac failure.

[105]  J. Mascherbauer,et al.  Presence of ´isolated´ tricuspid regurgitation should prompt the suspicion of heart failure with preserved ejection fraction , 2017, PloS one.

[106]  I. V. Van Gelder,et al.  Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume. , 2017, JACC. Heart failure.

[107]  T. Ryan,et al.  The Clinical Use of Stress Echocardiography in Non-Ischaemic Heart Disease: Recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. , 2017, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[108]  V. Melenovský,et al.  Role of Diastolic Stress Testing in the Evaluation for Heart Failure With Preserved Ejection Fraction: A Simultaneous Invasive-Echocardiographic Study , 2016, Circulation.

[109]  V. Melenovský,et al.  Abnormal right ventricular-pulmonary artery coupling with exercise in heart failure with preserved ejection fraction. , 2016, European heart journal.

[110]  M. Obokata,et al.  Effect of Sex Differences on the Association Between Stroke Risk and Left Atrial Anatomy or Mechanics in Patients With Atrial Fibrillation , 2016, Circulation. Cardiovascular imaging.

[111]  A. Voors,et al.  Right ventricular dysfunction in heart failure with preserved ejection fraction: a systematic review and meta‐analysis , 2016, European journal of heart failure.

[112]  S. Rosenkranz,et al.  Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension: A Pathophysiological Continuum. , 2016, Journal of the American College of Cardiology.

[113]  P. Ponikowski,et al.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.

[114]  D. Kass,et al.  Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap , 2016, Circulation.

[115]  Sanjiv J. Shah,et al.  Prognostic Relevance of Left Atrial Dysfunction in Heart Failure With Preserved Ejection Fraction , 2016, Circulation. Heart failure.

[116]  Patrizio Lancellotti,et al.  Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2016, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[117]  David A. Klein,et al.  Prognostic Utility and Clinical Significance of Cardiac Mechanics in Heart Failure With Preserved Ejection Fraction: Importance of Left Atrial Strain , 2016, Circulation. Cardiovascular imaging.

[118]  Akshay S. Desai,et al.  Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction. , 2016, European heart journal.

[119]  W. Kraus,et al.  Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial. , 2016, JAMA.

[120]  E. González-López,et al.  Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. , 2015, European heart journal.

[121]  Sanjiv J. Shah,et al.  Prognostic Importance of Impaired Systolic Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone , 2015, Circulation.

[122]  V. Melenovský,et al.  Left Atrial Remodeling and Function in Advanced Heart Failure With Preserved or Reduced Ejection Fraction , 2015, Circulation. Heart failure.

[123]  N. Houstis,et al.  Mechanisms of Exercise Intolerance in Heart Failure With Preserved Ejection Fraction: The Role of Abnormal Peripheral Oxygen Extraction , 2015, Circulation. Heart failure.

[124]  Rahul C. Deo,et al.  Phenomapping for Novel Classification of Heart Failure With Preserved Ejection Fraction , 2015, Circulation.

[125]  J. Sanderson,et al.  Left ventricular long-axis performance during exercise is an important prognosticator in patients with heart failure and preserved ejection fraction. , 2015, International journal of cardiology.

[126]  V. Roger,et al.  Right Ventricular Function in Heart Failure With Preserved Ejection Fraction: A Community-Based Study , 2014, Circulation.

[127]  Grace Lin,et al.  Right heart dysfunction in heart failure with preserved ejection fraction. , 2014, European heart journal.

[128]  O. Smiseth,et al.  A systematic review of diastolic stress tests in heart failure with preserved ejection fraction, with proposals from the EU‐FP7 MEDIA study group , 2014, European journal of heart failure.

[129]  L. Georgievska-Ismail,et al.  Echocardiographic Predictors of Chronotropic Incompetence to Exercise in Patients with Heart Failure with Preserved Ejection Fraction , 2014, PRILOZI.

[130]  Ambarish Pandey,et al.  Exercise Training in Patients With Heart Failure and Preserved Ejection Fraction: Meta-Analysis of Randomized Control Trials , 2014, Circulation. Heart failure.

[131]  J. McMurray,et al.  Impaired left atrial function in heart failure with preserved ejection fraction , 2014, European journal of heart failure.

[132]  V. Melenovský,et al.  Implications of coronary artery disease in heart failure with preserved ejection fraction. , 2014, Journal of the American College of Cardiology.

[133]  M. Obokata,et al.  Left atrial strain provides incremental value for embolism risk stratification over CHA₂DS₂-VASc score and indicates prognostic impact in patients with atrial fibrillation. , 2014, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[134]  S. Solomon,et al.  Impaired systolic function by strain imaging in heart failure with preserved ejection fraction. , 2014, Journal of the American College of Cardiology.

[135]  R. Arena,et al.  Tricuspid annular plane systolic excursion and pulmonary arterial systolic pressure relationship in heart failure: an index of right ventricular contractile function and prognosis. , 2013, American journal of physiology. Heart and circulatory physiology.

[136]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[137]  V. Roger,et al.  Temporal Relationship and Prognostic Significance of Atrial Fibrillation in Heart Failure Patients With Preserved Ejection Fraction: A Community-Based Study , 2013, Circulation.

[138]  Bruce D. Johnson,et al.  Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction , 2013, European journal of heart failure.

[139]  M. Obokata,et al.  Incremental diagnostic value of la strain with leg lifts in heart failure with preserved ejection fraction. , 2013, JACC. Cardiovascular imaging.

[140]  V. Roger,et al.  Longitudinal Changes in Ejection Fraction in Heart Failure Patients With Preserved and Reduced Ejection Fraction , 2012, Circulation. Heart failure.

[141]  James D. Thomas,et al.  Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis , 2012, Heart.

[142]  D. Kitzman,et al.  Effect of endurance training on the determinants of peak exercise oxygen consumption in elderly patients with stable compensated heart failure and preserved ejection fraction. , 2012, Journal of the American College of Cardiology.

[143]  Adrian F Hernandez,et al.  Trends in Patients Hospitalized With Heart Failure and Preserved Left Ventricular Ejection Fraction: Prevalence, Therapies, and Outcomes , 2012, Circulation.

[144]  R. McKelvie,et al.  Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction , 2011, Circulation.

[145]  D. Kitzman,et al.  Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction. , 2011, Journal of the American College of Cardiology.

[146]  Sungha Park,et al.  Clinical outcomes of exercise-induced pulmonary hypertension in subjects with preserved left ventricular ejection fraction: implication of an increase in left ventricular filling pressure during exercise , 2011, Heart.

[147]  Amir Lerman,et al.  Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. , 2010, Journal of the American College of Cardiology.

[148]  R. Nishimura,et al.  Exercise Hemodynamics Enhance Diagnosis of Early Heart Failure With Preserved Ejection Fraction , 2010, Circulation. Heart failure.

[149]  V. Roger,et al.  Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction. , 2009, Journal of the American College of Cardiology.

[150]  Yu Ting Tan,et al.  The pathophysiology of heart failure with normal ejection fraction: exercise echocardiography reveals complex abnormalities of both systolic and diastolic ventricular function involving torsion, untwist, and longitudinal motion. , 2009, Journal of the American College of Cardiology.

[151]  V. Roger,et al.  Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. , 2009, Journal of the American College of Cardiology.

[152]  Mustafa Kurt,et al.  Left Atrial Function in Diastolic Heart Failure , 2009, Circulation. Cardiovascular imaging.

[153]  C. Lang,et al.  Prognostic significance and measurement of exercise-derived hemodynamic variables in patients with heart failure. , 2007, Journal of cardiac failure.

[154]  D. Kass,et al.  Impaired Chronotropic and Vasodilator Reserves Limit Exercise Capacity in Patients With Heart Failure and a Preserved Ejection Fraction , 2006, Circulation.

[155]  C. Appleton,et al.  A simple method for noninvasive estimation of pulmonary vascular resistance. , 2003, Journal of the American College of Cardiology.

[156]  D. Kass,et al.  Diastolic Compliance of Hypertrophied Ventricle Is Not Acutely Altered by Pharmacologic Agents Influencing Active Processes , 1993, Annals of Internal Medicine.

[157]  M. Guazzi,et al.  Left Atrial Dynamics During Exercise in Mitral Regurgitation of Primary and Secondary Origin: Pathophysiological Insights by Exercise Echocardiography Combined With Gas Exchange Analysis. , 2019, JACC. Cardiovascular imaging.

[158]  Simon Gibbs,et al.  [2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension]. , 2015, Kardiologia polska.

[159]  J. Afilalo,et al.  Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography , 2014 .